Muscle Afferent Feedback Effects in Patients with Heart Failure
心力衰竭患者的肌肉传入反馈效应
基本信息
- 批准号:8417378
- 负责人:
- 金额:$ 37.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAffectAgeAnimalsAttenuatedBicyclingBlood CirculationBlood PressureBlood flowBlood specimenCharacteristicsChronicComplexDevelopmentDevicesDyspneaEnvironmental air flowExerciseExercise ToleranceFatigueFeedbackFentanylFiberFigs - dietaryGene ExpressionGoalsHealthHeart RateHeart failureHumanInfusion proceduresIntramuscularKneeLegLeukocytesLimb structureLinkMagnetismMolecularMolecular TargetMorbidity - disease rateMuscleNerveNeuraxisP2X-receptorPatientsPeripheralPharmacologic SubstancePhysical activityPlayPopulationPublishingQuality of lifeReflex actionRegulationRelative (related person)ResearchRestRoleSkeletal MuscleSourceSpecificitySymptomsTRPV1 geneTechniquesTherapeutic InterventionTimeTissue-Specific Gene ExpressionUnited StatesVascular resistanceWorkbasedesigndisabilityexcessive exerciseexhaustionfemoral nerveimprovedinsightmRNA Expressionmortalitymuscle formprematurepublic health relevancequadriceps musclereceptorrelating to nervous systemresearch studyresponsetreatment strategyvasoconstrictionwillingness
项目摘要
DESCRIPTION (provided by applicant): Patients with chronic heart failure (HF) are characterized by disability and exercise intolerance which impair their quality of life and depict major source of morbidity in this population. Cardinal determinants of these characteristics include excessive exercise pressor reflex, premature fatigue, and exertional dyspnea. Abnormally elevated neural feedback from mechano- and/or metabosensitive group III and IV muscle afferents might play a key role in these abnormalities. However, even in healthy humans, our understanding of the exact role/relative contribution of group III/IV afferents to the circulatory and ventilatory control during exercise and the development of fatigue is incomplete. By studying both HF patients and age- and activity-matched healthy controls (CTRLs), we will evaluate the impact of HF on the relative contribution of these muscle afferents to a) the circulatory/ventilatory control, and b) the development of central and peripheral fatigue during exercise. Additionally, the proposed research will examine whether HF affects the expression of genes linked to metabosensitive receptors on muscle afferents and the functional impact of these changes in terms of central fatigue. Specifically, we will use lumbar intrathecal fentanyl to
block the central projection of group III/IV muscle afferents during exercise (no concomitant effect on feedforward drive). This unique, previously proven approach will enable us to evaluate the effects of group III/IV muscle afferents on leg blood flow, heart rate, blood pressure and ventilation during large and small muscle mass rhythmic exercise (bicycle and single leg knee-extension), and the development of central and peripheral fatigue (using magnetic femoral nerve stimulation techniques). Furthermore, we will take baseline and post-exercise blood samples from HF patients and CTRLs to determine the expression (mRNA) of ASIC3, P2X, and TRPV1 metaboreceptors on leukocytes in each population. Finally, to determine the specific contribution of these metabosensitive molecular receptors to the development of central fatigue in HF patients and CTRLs, we will perform an intramuscular infusion of a "metabolite soup" into the unfatigued quadriceps muscle. We have designed the "soup" to exclusively activate ASIC3, P2X, and TRPV1 metaboreceptors and have previously verified its specificity in published animal and human studies. Based on recent findings suggesting blunted metaboreceptor sensitivity in HF patients vs. CTRLs, we expect, following the specific stimulation of metaboreceptors due to the intramuscular soup infusion, greater central fatigue in CTRLs vs HF patients. The results from this analysis will contribute to a better understanding of the role of metaboreceptors as a potential mechanism underlying central fatigue and reflex abnormalities characterizing exercising HF patients. Combined, this research will provide new insight into the impact of HF on neural feedback and its role in the control of circulation and ventilation and the development of fatigue during physical activity. Furthermore, our experiments will identify potential molecular targets for therapeutic interventions with the overall purpose to improve the quality of life in patients with HF.
描述(由申请人提供):慢性心力衰竭(HF)患者的特征是残疾和运动不耐受,这损害了他们的生活质量,是该人群发病率的主要来源。这些特征的主要决定因素包括过度运动加压反射、过早疲劳和劳力性呼吸困难。机械和/或代谢敏感的第III和IV组肌肉传入神经反馈异常升高可能在这些异常中发挥关键作用。然而,即使在健康的人,我们的确切作用/相对贡献的第III/IV组传入运动和疲劳的发展过程中的循环和排泄控制的理解是不完整的。通过研究HF患者和年龄和活动匹配的健康对照(CTR),我们将评估HF对这些肌肉传入对a)循环/排泄控制和B)运动期间中枢和外周疲劳发展的相对贡献的影响。此外,拟议的研究将检查HF是否影响与肌肉传入神经上的代谢敏感受体相关的基因表达,以及这些变化对中枢疲劳的功能影响。具体来说,我们将使用腰椎鞘内芬太尼,
在运动过程中阻断III/IV组肌肉传入神经的中枢投射(对前馈驱动无伴随作用)。这种独特的,以前证明的方法将使我们能够评估第III/IV组肌肉传入对腿部血流量,心率,血压和通气的影响,在大肌肉和小肌肉质量的节奏运动(自行车和单腿膝盖伸展),以及中枢和外周疲劳的发展(使用磁股神经刺激技术)。此外,我们将从HF患者和CTR中采集基线和运动后血液样本,以确定每个群体中白细胞上ASIC 3、P2 X和TRPV 1代谢受体的表达(mRNA)。最后,为了确定这些代谢敏感性分子受体对HF患者和CTRL中枢疲劳发展的具体贡献,我们将向未疲劳的四头肌肌肉内输注“代谢物汤”。我们已经设计了专门激活ASIC 3,P2 X和TRPV 1代谢受体的“汤”,并且之前已经在已发表的动物和人类研究中验证了其特异性。基于最近的研究结果表明HF患者与CTRL相比代谢受体敏感性减弱,我们预计,在由于肌内汤输注引起的代谢受体的特异性刺激后,CTRL与HF患者相比中枢疲劳更大。这项分析的结果将有助于更好地理解代谢受体作为运动HF患者特征性中枢疲劳和反射异常的潜在机制的作用。结合起来,这项研究将提供新的见解,HF对神经反馈的影响及其在控制循环和通气以及体力活动期间疲劳的发展中的作用。此外,我们的实验将确定治疗干预的潜在分子靶点,其总体目的是改善HF患者的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARKUS AMANN其他文献
MARKUS AMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARKUS AMANN', 18)}}的其他基金
Autonomic Dysfunction in Patients with HFpEF
HFpEF 患者的自主神经功能障碍
- 批准号:
10587484 - 财政年份:2023
- 资助金额:
$ 37.28万 - 项目类别:
Efficacy of exercise training in patients with HFpEF
运动训练对 HFpEF 患者的疗效
- 批准号:
10700031 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Efficacy of exercise training in patients with HFpEF
运动训练对 HFpEF 患者的疗效
- 批准号:
10063375 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Efficacy of exercise training in patients with HFpEF
运动训练对 HFpEF 患者的疗效
- 批准号:
10327281 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Premature fatigue in veterans with heart failure: neuronal influences
患有心力衰竭的退伍军人过早疲劳:神经元影响
- 批准号:
8730935 - 财政年份:2014
- 资助金额:
$ 37.28万 - 项目类别:
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and Fatigue
慢性阻塞性肺病 (COPD) 中的呼吸和氧化应激作用:对血流和疲劳的影响
- 批准号:
8815194 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别:
Muscle Afferent Feedback Effects in Patients with Heart Failure
心力衰竭患者的肌肉传入反馈效应
- 批准号:
8617297 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别:
Muscle Afferent Feedback Effects In Patients With Heart Failure
心力衰竭患者的肌肉传入反馈效应
- 批准号:
9039133 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别:
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and Fatigue
慢性阻塞性肺病 (COPD) 中的呼吸和氧化应激作用:对血流和疲劳的影响
- 批准号:
8625822 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别:
Work of Breathing and Oxidative Stress in COPD: Impact on Blood Flow and Fatigue
慢性阻塞性肺病 (COPD) 中的呼吸和氧化应激作用:对血流和疲劳的影响
- 批准号:
8598651 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 37.28万 - 项目类别:
Standard Grant